Performance of the SafeTerm AI-Based MedDRA Query System Against Standardised MedDRA Queries
In pre-market drug safety review, grouping related adverse event terms into SMQs or OCMQs is critical for signal detection. We assess the performance of SafeTerm Automated Medical Query (AMQ) on MedDRA SMQs. The AMQ is a novel quantitative artificial intelligence system that understands and processes medical terminology and automatically retrieves relevant MedDRA Preferred Terms (PTs) for a given input query, ranking them by a relevance score (0-1) using multi-criteria statistical methods. The system (SafeTerm) embeds medical query terms and MedDRA PTs in a multidimensional vector space, then applies cosine similarity, and extreme-value clustering to generate a ranked list of PTs. Validation was conducted against tier-1 SMQs (110 queries, v28.1). Precision, recall and F1 were computed at multiple similarity-thresholds, defined either manually or using an automated method. High recall (94%)) is achieved at moderate similarity thresholds, indicative of good retrieval sensitivity. Higher thresholds filter out more terms, resulting in improved precision (up to 89%). The optimal threshold (0.70)) yielded an overall recall of (48%) and precision of (45%) across all 110 queries. Restricting to narrow-term PTs achieved slightly better performance at an increased (+0.05) similarity threshold, confirming increased relatedness of narrow versus broad terms. The automatic threshold (0.66) selection prioritizes recall (0.58) to precision (0.29). SafeTerm AMQ achieves comparable, satisfactory performance on SMQs and sanitized OCMQs. It is therefore a viable supplementary method for automated MedDRA query generation, balancing recall and precision. We recommend using suitable MedDRA PT terminology in query formulation and applying the automated threshold method to optimise recall. Increasing similarity scores allows refined, narrow terms selection.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
Automated Generation of Custom MedDRA Queries Using SafeTerm Medical Map
In pre-market drug safety review, grouping related adverse event terms into standardised MedDRA queries or the FDA Office of New Drugs Custom Medical Queries (OCMQs) is critical for signal detection. We present a novel q…
Automated PRO-CTCAE Symptom Selection based on Prior Adverse Event Profiles
The PRO-CTCAE is an NCI-developed patient-reported outcome system for capturing symptomatic adverse events in oncology trials. It comprises a large library drawn from the CTCAE vocabulary, and item selection for a given …
Knowledge-based Graphical Method for Safety Signal Detection in Clinical Trials
We present a graphical, knowledge-based method for reviewing treatment-emergent adverse events (AEs) in clinical trials. The approach enhances MedDRA by adding a hidden medical knowledge layer (Safeterm) that captures se…
Ontology-based Semantic Similarity Measures for Clustering Medical Concepts in Drug Safety
Semantic similarity measures (SSMs) are widely used in biomedical research but remain underutilized in pharmacovigilance. This study evaluates six ontology-based SSMs for clustering MedDRA Preferred Terms (PTs) in drug s…
ClusteringPharmacovigilanceSemantic SimilaritySemantic Textual SimilarityPVLens: Enhancing Pharmacovigilance Through Automated Label Extraction
Reliable drug safety reference databases are essential for pharmacovigilance, yet existing resources like SIDER are outdated and static. We introduce PVLens, an automated system that extracts labeled safety information f…
Pharmacovigilance